Riomet Er patents expiration

RIOMET ER's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9962336 SUN PHARM Extended release suspension compositions
May, 2035

(11 years from now)

Riomet Er is owned by Sun Pharm.

Riomet Er contains Metformin Hydrochloride.

Riomet Er has a total of 1 drug patent out of which 0 drug patents have expired.

Riomet Er was authorised for market use on 29 August, 2019.

Riomet Er is available in for suspension, extended release;oral dosage forms.

The generics of Riomet Er are possible to be released after 01 May, 2035.

Drugs and Companies using METFORMIN HYDROCHLORIDE ingredient

Market Authorisation Date: 29 August, 2019

Treatment: NA


More Information on Dosage

RIOMET ER family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic